logo

Adicet Bio, Inc (ACET)



Trade ACET now with
  Date
  Headline
8/10/2022 7:03:50 AM Adicet Bio Q2 Loss Per Share $0.56 Vs Loss $0.34 Last Year
6/6/2022 7:03:57 AM Adicet Bio Reports Positive Emerging Data From ADI-001 Phase 1 Trial At ASCO Annual Meeting
5/12/2022 4:17:36 PM Adicet Bio Q1 EPS $0.10 Vs. Loss $0.82 Year Ago
4/27/2022 10:05:54 AM Adicet Bio Announces Oral Presentation Of Updated ADI-001 Phase 1 Data
4/19/2022 7:05:35 AM Adicet Bio: FDA Grants Fast Track Designation For ADI-001 For Potential Treatment Of R/r B-cell Non-Hodgkin's Lymphoma
3/16/2022 10:23:44 AM Wedbush Is Raising Adicet Bio, Inc (ACET) FY 22 Rev. Estimate To 23.5 M From 3.5 M
3/16/2022 10:23:27 AM Wedbush Is Raising Adicet Bio, Inc (ACET) Q1 22 Rev. Estimate To 23.5 M From 3.5 M
3/16/2022 10:22:33 AM Wedbush Is Raising Adicet Bio, Inc (ACET) FY 22 Estimate To -2.17 From -2.26
3/16/2022 10:22:11 AM Wedbush Is Cutting Adicet Bio, Inc (ACET) Q4 22 Estimate To -0.79 From -0.58
3/16/2022 10:21:56 AM Wedbush Is Increasing Adicet Bio, Inc (ACET) Q3 22 Estimate To 0.75 From -0.55
3/16/2022 10:21:39 AM Wedbush Is Increasing Adicet Bio, Inc (ACET) Q2 22 Estimate To 0.71 From -0.64
3/16/2022 10:21:23 AM Wedbush Is Increasing Adicet Bio, Inc (ACET) Q1 22 Estimate To 0.08 From -0.49
3/16/2022 10:20:43 AM Wedbush Reiterates Adicet Bio, Inc (ACET) At Outperform With $25 Price Target
3/15/2022 4:08:18 PM Adicet Bio Q4 Loss/share $0.47 Vs. Loss $0.46 Year Ago
8/17/2021 8:07:48 AM Wedbush Is Raising Adicet Bio, Inc (ACET) FY22 Estimate To -2.16 From -2.79
8/17/2021 8:07:33 AM Wedbush Is Raising Adicet Bio, Inc (ACET) Q4 22 Estimate To -0.55 From -0.72